Allogeneic hematopoietic stem cell transplantation is a definitive therapy for a variety of
disorders. One of the complications is acute graft-versus-host disease (aGVHD), which has a …

Ocular graft-versus-host disease (GVHD) occurs in more than half of patients who develop
chronic GVHD after allogeneic hematopoietic cell transplantation (HCT), causing prolonged …

Graft-versus-host disease is a common complication following allogeneic hematopoetic
stem cell transplantation that can affect multiple organ systems, including the eyes. Ocular …

Graft-versus-host disease (GVHD) is a major complication that occurs following allogeneic
hematopoietic stem cell transplantation, which is a potential curative therapy used in a …

Ocular graft-versus-host-disease (GVHD) remains a significant clinical complication after
allogeneic hematopoietic stem cell transplantation. Impaired visual function, pain, and other …

Purpose To evaluate the safety and efficacy of topical tacrolimus 0.05% versus topical
methylprednisolone 0.5% in patients with ocular graft-versus-host disease (GVHD). Design …

Ocular graft-versus-host disease (GVHD) is a major complication after allogeneic
hematopoietic stem cell transplantation. Ocular GVHD affects recipients' visual function and …

Immune mediated inflammatory anterior segment diseases are variable and their
management requires intense immunosuppression. Treatment with topical steroids is …

Despite the use of high-resolution molecular techniques for tissue typing, chronic graft-
versus-host disease (cGVHD) remains a major complication following allogeneic …

Purpose To evaluate the effects of 0.1% topical tacrolimus alone or in combination with
steroids for the treatment of shield ulcers and corneal epitheliopathy in patients with …